AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 4; New/Revised ICD-10-PCS Codes Section X – New Technology
Rapid Antimicrobial Susceptibility Testing System for Blood and Body Fluid Cultures Using Phenotypic Susceptibility
In table XXE, body part 5 Circulatory, technology value Y Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, was added to identify rapid antimicrobial susceptibility testing of positive blood and body fluid cultures using phenotypic susceptibility.Body Part Approach Device/Substance/ Technology Qualifier 5 Circulatory X External Y Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology 9 New Technology Group 9 Blood stream infections are diagnosed by a positive blood culture followed by gram staining, microbial identification, and antimicrobial susceptibility testing (AST). AST is performed in a clinical laboratory to determine if disease causing bacteria are phenotypically resistant...
Subscribe or sign in to view the full article.
Article Overview
This article explains a new technology classification related to rapid antimicrobial susceptibility testing for positive blood and body fluid cultures. It is relevant to coding and reimbursement professionals who track updates to inpatient procedure coding, new technology designations, and laboratory-based infection testing technologies. The discussion places the update in the context of bloodstream infection workups, phenotypic susceptibility testing, and a named rapid AST platform.
Why This Topic Matters
Updates like this can affect how emerging laboratory technologies are classified and tracked in medical coding systems. Understanding the scope helps coders, auditors, and revenue cycle teams recognize when a new technology designation applies to blood and body fluid culture testing services.
Article Sections
-
New technology classification update
Introduces the classification change for a rapid antimicrobial susceptibility testing technology associated with positive blood and body fluid cultures.
-
Technology category details
Summarizes the body system, approach, device or technology grouping, qualifier, and new technology group designation associated with the update.
-
Background on bloodstream infection testing
Provides general context on how bloodstream infections are evaluated in clinical laboratories and the role of antimicrobial susceptibility testing.
-
Platform overview
Describes the named rapid testing platform and its general purpose within phenotypic susceptibility testing.
What You Will Learn
- What type of technology update is being discussed
- How the article frames the laboratory context for bloodstream infection testing
- What broad category of rapid susceptibility testing technology is involved
- Which clinical testing workflow the article uses as background
- Which general technology platform is referenced
Who Should Read This
- Inpatient coders
- Coding auditors
- Clinical documentation improvement professionals
- Revenue cycle staff
- Health information management professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com